-
Loading metrics
Open Access
Peer-reviewed
Research Article
The influence of rare variants in circulating metabolic biomarkers
-
Fernando Riveros-Mckay,
Roles Formal analysis, Investigation, Methodology, Validation, Visualization
Affiliation Wellcome Sanger Institute, Cambridge, United Kingdom
⨯ -
Clare Oliver-Williams,
Roles Formal analysis, Investigation, Methodology
Affiliations MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Homerton College, Cambridge, United Kingdom
⨯ -
Savita Karthikeyan,
Roles Formal analysis, Investigation
Affiliation MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
⨯ -
Klaudia Walter,
Roles Data curation, Investigation, Resources
Affiliation Wellcome Sanger Institute, Cambridge, United Kingdom
⨯ -
Kousik Kundu,
Roles Data curation, Investigation, Resources
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom
⨯ -
Willem H. Ouwehand,
Roles Funding acquisition, Resources
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom, NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom
⨯ -
David Roberts,
Roles Funding acquisition, Resources
Affiliations The National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, NHS Blood and Transplant—Oxford Centre, Level 2, John Radcliffe Hospital, Oxford, United Kingdom, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
⨯ -
Emanuele Di Angelantonio,
Roles Funding acquisition, Resources
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, The National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom, Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
⨯ -
Nicole Soranzo,
Roles Resources, Supervision
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom
⨯ -
John Danesh,
Roles Funding acquisition, Resources
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, The National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom, Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
⨯ -
INTERVAL Study ,
¶Members of the INTERVAL Study are listed in the Acknowledgments.
⨯ -
Eleanor Wheeler,
Roles Supervision
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, MRC Epidemiology Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom
⨯ -
Eleftheria Zeggini,
Roles Supervision, Writing – review & editing
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, Institute of Translational Genomics, Helmholtz Zentrum München—German Research Center for Environmental Health, Neuherberg, Germany
⨯ -
Adam S. Butterworth,
Roles Funding acquisition, Resources, Supervision, Writing – review & editing
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, The National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, United Kingdom, Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
⨯ -
Inês Barroso
Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: ines.barroso@exeter.ac.uk
Affiliations Wellcome Sanger Institute, Cambridge, United Kingdom, MRC Epidemiology Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom
⨯
The influence of rare variants in circulating metabolic biomarkers
- Fernando Riveros-Mckay,
- Clare Oliver-Williams,
- Savita Karthikeyan,
- Klaudia Walter,
- Kousik Kundu,
- Willem H. Ouwehand,
- David Roberts,
- Emanuele Di Angelantonio,
- Nicole Soranzo,
- John Danesh
-
- Published: March 9, 2020
- https://doi.org/10.1371/journal.pgen.1008605